Patents Assigned to VESTION, INC.
  • Patent number: 10874698
    Abstract: Compositions comprising stem cells delivered into infarcted myocardium by endocardial injection, engraft and differentiate into myocytes, endothelial cells, and vascular smooth muscle, and do so without the requirement for survival enhancing modification. These cells engraft whether injected acutely (days) or late (months) after myocardial infarction, and the efficiency of engraftment correlates with the functional recovery of the heart. The stem cells also recruit endogenous cardiac precursor cells, reconstitute myocardial stem cell niches, and enhance endogenous cell differentiation into myocytes.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: December 29, 2020
    Assignee: VESTION, INC.
    Inventors: Joshua Hare, Konstantinos Chatzistergos, Alan W. Heldman
  • Patent number: 10786536
    Abstract: Cardiac neural crest cells and methods for making and using the same to effect cardiac injury is described herein.
    Type: Grant
    Filed: October 29, 2014
    Date of Patent: September 29, 2020
    Assignee: VESTION, INC.
    Inventors: Konstantinos E. Chatzistergos, Joshua M. Hare
  • Patent number: 10709742
    Abstract: Compositions comprising stem cells delivered into infarcted myocardium by endocardial injection engraft and differentiate into myocytes, endothelial cells, and vascular smooth muscle, and do so without the requirement for survival enhancing modification. These cells engraft whether injected acutely (days) or late (months) after myocardial infarction, and the efficiency of engraftment correlates with the functional recovery of the heart. The stem cells also recruit endogenous cardiac precursor cells, reconstitute myocardial stem cell niches, and enhance endogenous cell differentiation into myocytes.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: July 14, 2020
    Assignee: VESTION, INC.
    Inventors: Joshua Hare, Konstantinos Chatzistergos, Alan W. Heldman
  • Patent number: 10481147
    Abstract: Methods of isolating cardiac cells, including cardiac cells capable of regenerating cardiac tissue are provided. Compositions comprising cardiac cells, including cardiac cells capable of regenerating cardiac tissue are also provided. Methods of using cardiac cells, cardiac progenitor cells, including cardiac cells capable of regenerating cardiac tissue, are provided. Methods of identifying the prognosis of patients treated for heart disease and/or methods of predicting the regeneration of cardiac cells in a subject are also provided.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: November 19, 2019
    Assignee: VESTION, INC.
    Inventors: Joshua Hare, Konstantinos Chatzistergos
  • Patent number: 9980985
    Abstract: Compositions comprising stem cells delivered into infarcted myocardium by endocardial injection, engraft and differentiate into myocytes, endothelial cells, and vascular smooth muscle, and do so without the requirement for survival enhancing modification. These cells engraft whether injected acutely (days) or late (months) after myocardial infarction, and the efficiency of engraftment correlates with the functional recovery of the heart. The stem cells also recruit endogenous cardiac precursor cells, reconstitute myocardial stem cell niches, and enhance endogenous cell differentiation into myocytes.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: May 29, 2018
    Assignee: Vestion, Inc.
    Inventors: Joshua Hare, Konstantinos Chatzistergos, Alan W. Heldman
  • Patent number: 9962409
    Abstract: Compositions comprising stem cells delivered into infarcted myocardium by endocardial injection, engraft and differentiate into myocytes, endothelial cells, and vascular smooth muscle, and do so without the requirement for survival enhancing modification. These cells engraft whether injected acutely (days) or late (months) after myocardial infarction, and the efficiency of engraftment correlates with the functional recovery of the heart. The stem cells also recruit endogenous cardiac precursor cells, reconstitute myocardial stem cell niches, and enhance endogenous cell differentiation into myocytes.
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: May 8, 2018
    Assignee: Vestion, Inc.
    Inventors: Joshua Hare, Konstantinos Chatzistergos
  • Patent number: 9746457
    Abstract: Methods of isolating cardiac cells, including cardiac cells capable of regenerating cardiac tissue are provided. Compositions comprising cardiac cells, including cardiac cells capable of regenerating cardiac tissue are also provided. Methods of using cardiac cells, cardiac progenitor cells, including cardiac cells capable of regenerating cardiac tissue, are provided. Methods of identifying the prognosis of patients treated for heart disease and/or methods of predicting the regeneration of cardiac cells in a subject are also provided.
    Type: Grant
    Filed: December 2, 2013
    Date of Patent: August 29, 2017
    Assignee: Vestion, Inc.
    Inventors: Joshua Hare, Konstantinos Chatzistergos
  • Publication number: 20160250261
    Abstract: Cardiac neural crest cells and methods for making and using the same to effect cardiac injury is described herein.
    Type: Application
    Filed: October 29, 2014
    Publication date: September 1, 2016
    Applicant: VESTION, INC.
    Inventors: Konstantinos E. CHATZISTERGOS, Joshua M. HARE